Nuveen Asset Management’s X4 Pharmaceuticals XFOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-498,745
| Closed | -$334K | – | 3346 |
|
|
2024
Q3 | $334K | Hold |
498,745
| – | – | ﹤0.01% | 3125 |
|
|
2024
Q2 | $289K | Buy |
498,745
+60,631
| +14% | +$35.2K | ﹤0.01% | 3160 |
|
|
2024
Q1 | $609K | Hold |
438,114
| – | – | ﹤0.01% | 2909 |
|
|
2023
Q4 | $367K | Hold |
438,114
| – | – | ﹤0.01% | 3099 |
|
|
2023
Q3 | $478K | Hold |
438,114
| – | – | ﹤0.01% | 2857 |
|
|
2023
Q2 | $850K | Buy |
+438,114
| New | +$850K | ﹤0.01% | 2715 |
|
|
2021
Q2 | – | Sell |
-80,113
| Closed | -$689K | – | 3449 |
|
|
2021
Q1 | $689K | Sell |
80,113
-4,124
| -5% | -$35.5K | ﹤0.01% | 3012 |
|
|
2020
Q4 | $541K | Buy |
84,237
+1,141
| +1% | +$7.33K | ﹤0.01% | 3026 |
|
|
2020
Q3 | $562K | Buy |
83,096
+403
| +0.5% | +$2.73K | ﹤0.01% | 2915 |
|
|
2020
Q2 | $771K | Buy |
82,693
+38,829
| +89% | +$362K | ﹤0.01% | 2731 |
|
|
2020
Q1 | $439K | Buy |
43,864
+11,677
| +36% | +$117K | ﹤0.01% | 2809 |
|
|
2019
Q4 | $344K | Hold |
32,187
| – | – | ﹤0.01% | 2978 |
|
|
2019
Q3 | $409K | Buy |
32,187
+20,377
| +173% | +$259K | ﹤0.01% | 2999 |
|
|
2019
Q2 | $177K | Buy |
+11,810
| New | +$177K | ﹤0.01% | 3175 |
|